Clearmind Medicine Inc. short interest in 2025
In 2025, Clearmind Medicine Inc.'s disclosed short interest ran from 6.44% of shares outstanding on 14 Feb 2025 to 2.90% on 30 Jun 2025, a change of -3.54 percentage points. The year's high was 6.44% on 14 Feb 2025 and its low 2.48% on 30 May 2025, averaging 4.17% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.23 days on 28 Feb 2025. Full history: Clearmind Medicine Inc..
Cite this page
By year: 2023 · 2025
2025 in figures
- Start of year
- 6.44% (14 Feb 2025)
- End of year
- 2.90% (30 Jun 2025)
- Change
- -3.54 pp
- High
- 6.44% (14 Feb 2025)
- Low
- 2.48% (30 May 2025)
- Average
- 4.17%
- Highest days to cover
- 5.23 (28 Feb 2025)
- SEC filings marked
- 1
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Feb 2025 | 6.44% | 2.74 | 20-F filed |
| 28 Feb 2025 | 5.99% | 5.23 | |
| 14 Mar 2025 | 4.56% | 3.54 | |
| 31 Mar 2025 | 4.32% | 3.10 | |
| 15 Apr 2025 | 2.76% | 3.53 | |
| 30 Apr 2025 | 5.49% | 1.00 | |
| 15 May 2025 | 3.83% | 3.75 | |
| 30 May 2025 | 2.48% | 1.63 | |
| 13 Jun 2025 | 2.93% | 1.00 | |
| 30 Jun 2025 | 2.90% | 2.29 |
See also: Clearmind Medicine Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.